Advixa 40mg Injection is a medication containing the active ingredient infliximab, a monoclonal antibody that targets and inhibits tumor necrosis factor-alpha (TNF-α), a protein involved in the inflammatory response. Advixa 40mg Injection is used to treat various autoimmune and inflammatory conditions, such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and ankylosing spondylitis. By blocking TNF-α, Advixa helps reduce inflammation, pain, and damage caused by these conditions. The Advixa 40mg Injection is typically administered intravenously in a healthcare setting. As with other TNF inhibitors, it may increase the risk of infections and other side effects, necessitating careful monitoring during treatment.
